Voyager Therapeutics, Inc.
VYGR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001640266
No open-market purchases or sales by Voyager Therapeutics, Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $122.7M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Voyager Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 116
- −15 vs. Q4 2024
- Shares held
- 34.7M
- +239.2K (+0.7%) vs. Q4 2024
- Total value
- $117.4M
- −$78.1M (−39.9%) vs. Q4 2024
- New holders
- 13
- 34 more added
- Sold out
- 28
- 42 more reduced
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VYGR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $122.7M |
| Q1 2026 | 135 | $129.4M |
| Q4 2025 | 125 | $132.6M |
| Q3 2025 | 117 | $141.1M |
| Q2 2025 | 113 | $103.1M |
| Q1 2025 | 116 | $117.4M |
| Q4 2024 | 133 | $196.2M |
| Q3 2024 | 128 | $205.9M |
| Q2 2024 | 127 | $301.6M |
| Q1 2024 | 132 | $331.1M |
| Q4 2023 | 107 | $227.5M |
| Q3 2023 | 111 | $211.2M |
| Q2 2023 | 106 | $307.7M |
| Q1 2023 | 82 | $183.8M |
| Q4 2022 | 70 | $146.2M |
| Q3 2022 | 69 | $142.9M |
| Q2 2022 | 78 | $142.3M |
| Q1 2022 | 70 | $171.3M |
| Q4 2021 | 59 | $51.3M |
| Q3 2021 | 69 | $58.6M |
| Q2 2021 | 78 | $96.8M |
| Q1 2021 | 101 | $125.7M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Voyager Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 380,485 | $1.29M | 0.00% | −66,656−14.9% | Reduced |
| Northern Trust Corp | 412,019 | $1.39M | 0.00% | −6,726−1.6% | Reduced |
| AQR Capital Management LLC | 495,260 | $1.67M | 0.00% | +317,927+179.3% | Added |
| Price T Rowe Associates Inc | 622,522 | $2.10M | 0.00% | −239,910−27.8% | Reduced |
| Great Point Partners LLC | 626,275 | $2.12M | 1.15% | −200,476−24.2% | Reduced |
| Bank of America Corp | 680,276 | $2.30M | 0.00% | +661,504+3,523.9% | Added |
| State Street Corp | 902,752 | $3.05M | 0.00% | +1,820+0.2% | Added |
| Geode Capital Management, LLC | 1,104,918 | $3.74M | 0.00% | +20,680+1.9% | Added |
| Erste Asset Management GmbH | 1,116,793 | $3.83M | 0.05% | +58,415+5.5% | Added |
| Vestal Point Capital, LP | 1,249,418 | $4.22M | 0.30% | +19,418+1.6% | Added |
| Dimensional Fund Advisors LP | 1,496,284 | $5.06M | 0.00% | +115,669+8.4% | Added |
| Farallon Capital Management, L.L.C. | 2,570,700 | $8.69M | 0.05% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,211,083 | $10.9M | 0.00% | −4,358−0.1% | Reduced |
| EcoR1 Capital, LLC | 3,917,546 | $13.2M | 0.79% | 00.0% | Unchanged |
| BlackRock, Inc. | 5,412,290 | $18.3M | 0.00% | +55,501+1.0% | Added |
| Armistice Capital, LLC | 5,436,000 | $18.4M | 0.49% | +40,000+0.7% | Added |
| Prudential Financial Inc | 0 | $0 | 0.00% | −330,300−100.0% | Sold out |
| Globeflex Capital L P | 0 | $0 | 0.00% | −291,293−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −123,459−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −65,830−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −61,047−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −49,207−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −47,017−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −41,200−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −38,650−100.0% | Sold out |
| Virtus Investment Advisers, Inc. | 0 | $0 | 0.00% | −20,105−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −17,692−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −17,499−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −13,450−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −10,646−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −10,618−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −8,904−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −5,074−100.0% | Sold out |
| Plato Investment Management Ltd | 0 | $0 | 0.00% | −1,449−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,182−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −1,091−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −523−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −167−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −163−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −115−100.0% | Sold out |
| Richards, Merrill & Peterson, Inc. | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Sandy Spring Bank | 0 | $0 | 0.00% | 0 | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −148−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| Virtus Fund Advisers, LLC | – | – | – | – | Not filed |